Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection

Inclusion Criteria: * Male or female patients from 9 months of age up to 98 years of age. * Clinical diagnosis of impetigo, folliculitis, or minor soft tissue infection including secondarily infected eczema presumed to be caused by Staphylococcus aureus. * The patient, and if applicable the parent or guardian, is able to give informed consent * Females of child bearing potential have a negative urine pregnancy test. * Patient, and if applicable parent or guardian, are willing to and capable of complying with the study protocol. Exclusion Criteria: * Subject who has used a topical antibacterial medication to the area being treated within the last 48 hours. * Subject who has been enrolled in a clinical trial within the last 30 days. * Subject with signs of systemic infection (such as fever), or with evidence of abscess or cellulitis at the site to be treated. * Subject has a bacterial skin infection which would not be appropriately treated by a topical antibiotic in the opinion of the investigator * Subjects who have taken oral antibiotics within the last 7 days. * Subjects with known sensitivity to the study medication. * The subject is pregnant or breastfeeding